Acceptability of Long-Acting Injectable Antiretroviral Treatment for HIV Management: Perspectives of Patients and Physicians in Spain-Reference-Cited by-同舟云学术

Acceptability of Long-Acting Injectable Antiretroviral Treatment for HIV Management: Perspectives of Patients and Physicians in Spain

Published:2024-07-01 Issue:7 Volume:38 Page:305-314
ISSN:1087-2914
Container-title:AIDS Patient Care and STDs
language:en
Short-container-title:AIDS Patient Care and STDs

Author:

Moreno Cristina¹²^ORCID,Izquierdo Rebeca¹²^ORCID,Alejos Belén³,Hernando Victoria¹²,Pérez de la Cámara Santiago⁴,Peraire Joaquim²⁵,Macías Juan²⁶,Bernal Enrique⁷^ORCID,Albendín-Iglesias Helena⁸,Alcaraz Begoña⁹,Suárez-García Inés²¹⁰,Moreno Santiago²¹¹,Jarrín Inma¹²,

Affiliation:

1. National Centre for Epidemiology, Carlos III Health Institute, Madrid, Spain.

2. CIBERINFEC, Carlos III Health Institute, Madrid, Spain.

3. Independent Researcher, Madrid, Spain.

4. Carlos III Health Institute, Telemedicine and E-Health Unit, Madrid, Spain.

5. Pere Virgili Institute for Health Research (IISPV), Joan XXIII University Hospital, Rovira and Virgili University, Tarragona, Spain.

6. Department of Medicine, Institute of Biomedicine of Seville (IBiS), University of Seville, Virgen of Valme University Hospital, Seville, Spain.

7. Department of Infectious Diseases, Reina Sofía General University Hospital, Murcia, Spain.

8. HIV and STI Unit, Internal Medicine Department, Virgen of Arrixaca University Hospital, Biomedical Research Institute of Murcia (IMIB), Murcia, Spain.

9. Infectious Diseases Unit, Internal Medicine Department, Santa Lucía General University Hospital, Cartagena, Spain.

10. Infectious Diseases Group, Department of Internal Medicine, Infanta Sofía Hospital, Infanta Sofia University Hospital and Henares University Hospital Foundation for Biomedical Research and Innovation (FIIB HUIS HHEN), European University of Madrid, Madrid, Spain.

11. Department of Infectious Diseases, University Hospital Ramón y Cajal, Ramón y Cajal Health Research Institute (IRYCIS), University of Alcalá, Madrid, Spain.

Publisher

Mary Ann Liebert Inc

Link

https://www.liebertpub.com/doi/pdf/10.1089/apc.2024.0093

Reference28 articles.

1. Long-acting injectable antiretroviral therapy: will it change the future of HIV treatment?

2. The end of AIDS: HIV infection as a chronic disease

3. Long-acting antiretrovirals: a new era for the management and prevention of HIV infection

4. Barriers to Uptake of Long-Acting Antiretroviral Products for Treatment and Prevention of Human Immunodeficiency Virus (HIV) in High-Income Countries